IRIS UniCatt

Fasano, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.209
EU - Europa 3.595
AS - Asia 2.836
SA - Sud America 497
AF - Africa 84
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.107
SG - Singapore 1.311
DE - Germania 1.306
CN - Cina 753
SE - Svezia 514
BR - Brasile 378
FR - Francia 330
UA - Ucraina 330
IT - Italia 300
VN - Vietnam 226
GB - Regno Unito 211
IE - Irlanda 176
IN - India 117
FI - Finlandia 97
ID - Indonesia 93
RU - Federazione Russa 85
PL - Polonia 83
JP - Giappone 66
CA - Canada 50
TR - Turchia 46
AR - Argentina 45
BD - Bangladesh 37
NL - Olanda 34
HK - Hong Kong 32
ES - Italia 28
MX - Messico 28
ZA - Sudafrica 25
BE - Belgio 24
IQ - Iraq 21
EC - Ecuador 20
CI - Costa d'Avorio 19
AT - Austria 16
AU - Australia 16
SA - Arabia Saudita 16
IR - Iran 14
PK - Pakistan 14
MA - Marocco 12
PY - Paraguay 12
VE - Venezuela 12
CO - Colombia 11
BG - Bulgaria 10
LT - Lituania 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
GR - Grecia 8
IL - Israele 8
KE - Kenya 7
NP - Nepal 7
PH - Filippine 7
TN - Tunisia 7
BO - Bolivia 6
JM - Giamaica 6
JO - Giordania 6
KR - Corea 6
KZ - Kazakistan 6
UZ - Uzbekistan 6
CL - Cile 5
DK - Danimarca 5
RO - Romania 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
MY - Malesia 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
UY - Uruguay 4
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GY - Guiana 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AM - Armenia 1
BH - Bahrain 1
BS - Bahamas 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 11.237
Salva come PNG Salva come JPEG
Città #
Singapore 717
Chandler 573
Ashburn 474
San Jose 336
Dublin 172
Jacksonville 168
Beijing 141
San Mateo 137
New York 124
Nanjing 94
Wilmington 91
Los Angeles 86
Jakarta 84
Lauterbourg 80
Ho Chi Minh City 79
Ann Arbor 78
Dallas 77
Nürnberg 73
Hanoi 70
Warsaw 70
Dearborn 66
Boston 65
Woodbridge 63
Houston 62
Lawrence 56
Seattle 56
Tokyo 49
Munich 47
Fairfield 46
Frankfurt am Main 44
Lancaster 43
Hefei 42
Marseille 42
Milan 37
São Paulo 37
Nanchang 36
Redwood City 34
Cattolica 33
Moscow 32
Santa Clara 31
Rome 29
Buffalo 28
The Dalles 28
Redmond 27
Council Bluffs 26
Hong Kong 26
London 26
University Park 26
Shenyang 24
Norwalk 23
Princeton 23
Shanghai 23
Bremen 22
Izmir 22
Mountain View 22
Jiaxing 21
Atlanta 20
Brussels 20
Chicago 20
Abidjan 19
Hangzhou 19
Leawood 19
Boardman 18
Brooklyn 17
Changsha 17
Hebei 17
Orem 17
Montreal 16
Chennai 15
Stockholm 15
Phoenix 14
Fremont 13
Lappeenranta 13
Pune 13
Tianjin 13
Toronto 13
Augusta 12
Cambridge 12
Guangzhou 12
Helsinki 12
Kent 12
Paris 12
Rio de Janeiro 12
Simi Valley 12
Denver 11
Johannesburg 11
Kunming 11
Vienna 11
Zhengzhou 11
Brasília 10
Düsseldorf 10
Amsterdam 9
Ankara 9
Da Nang 9
Poitiers 9
Baku 8
Belo Horizonte 8
Curitiba 8
Mexico City 8
Quito 8
Totale 5.616
Salva come PNG Salva come JPEG
Nome #
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 273
The role of small intestinal bacterial overgrowth in Parkinson's disease 253
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 223
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 215
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 212
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 198
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 193
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 189
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 188
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 186
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 185
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 180
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 177
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 174
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease 171
Reliability of Clinical Diagnosis of Dystonia 168
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 167
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 166
Movement disorders in multiple sclerosis: Causal or coincidental association? 163
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 160
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 160
New olfactometric findings in Parkinson's disease 160
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 159
Dystonia gravidarum: a new case with a long follow-up 156
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 154
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 154
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 153
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 152
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 151
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 151
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 150
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 149
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 148
Punding and computer addiction in Parkinson's disease 146
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 145
Analysis of blink rate in patients with blepharospasm 144
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 143
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 143
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 142
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 142
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 140
Homotoxicology remedies versu desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial. 139
Management of status dystonicus: our experience and review of the literature 136
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. 135
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 134
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 132
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 131
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 131
Onset and progression of primary torsion dystonia in sporadic and familial cases 130
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 129
RARE AND SERIOS CARDIAC SIDE EFFECTS DURING ROPINIROLE TITRATION 128
The long-term effect of tetrabenazine in the management of Huntington disease 126
Tourettism in multiple sclerosis: a case report 126
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 123
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 123
Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis 123
Rare and serious cardiac side effects during ropinirole titration 122
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 120
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 116
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion 116
Humanitarian mission improves health conditions of schoolchildren in Ethiopia. the case of Adwa 115
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 115
Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: The Centro per la Lotta Contro L'infarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE study 114
Role of optical coherence tomography for distal left main stem angioplasty 109
Acute necrotizing encephalopathy: a relapsing case in a European adult 108
Tetrabenazine 108
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 108
Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study 108
Pisa syndrome in Parkinson disease 103
Retrospective evaluation of the dose equivalence of Botox and Dysport in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story 97
Treatment of dystonia using trihexyphenidyl in costello syndrome 97
Long-term effects of pedunculopontine nucleus stimulation for pisa syndrome 96
Status dystonicus: predictors of outcome and progression patterns of underlying disease 95
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 93
Punding (PD) 92
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life 92
Movement disorders phenomenology in focal motor seizures 91
Psychogenic facial movement disorders: Clinical features and associated conditions 82
Implementation of the Current Dystonia Classification from 2013 to 2018 82
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease. 59
Totale 11.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022787 63 79 20 45 44 26 21 119 35 69 114 152
2022/20231.562 183 211 119 226 115 197 80 144 190 21 57 19
2023/2024690 39 208 21 30 11 109 32 36 11 34 95 64
2024/20251.252 23 48 118 48 146 36 22 77 196 110 224 204
2025/20263.583 538 107 241 431 635 177 625 193 201 270 97 68
2026/202790 90 0 0 0 0 0 0 0 0 0 0 0
Totale 11.367